RVMD
Revolution Medicines, Inc.
NASDAQ · USHealthcareBiotechnology
$180.39-3.10%
Price as of Jul 20, 2026
RVMD valuation
Revolution Medicines, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 316.69x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 25.57x
- Price / sales
- —
- Price / cash flow
- -36.27x
Enterprise value
- Enterprise value
- $36.9B
- EV / sales
- —
- EV / EBITDA
- -27.97x
- EV / EBIT
- -26.59x
- Market cap
- $38.4B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.